✦ LIBER ✦

PD-079 Should chemotherapy combinations for advanced non-small cell lung cancer (NSCLC) be platinum-based? A literature-based meta-analysis of phase III randomised trials

✍ Scribed by Pujol, J.; Barlesi, F.; Daures, J.

Book ID: 118572826
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 146 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80412-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should chemotherapy combinations for adv

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

✍ Pujol, Jean-Louis; Barlesi, Fabrice; Daurès, Jean-Pierre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB

O-233 Platinum-based versus non-platinum

O-233 Platinum-based versus non-platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC): A meta-analysis of the published literature

✍ D'Addario, Giannicola; Pintillie, Melania; Cerny, Thomas; Feld, Ronald; Leighl, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Platinum-based combination chemotherapy

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B

✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received

P-43 Randomised phase III trial of docet

P-43 Randomised phase III trial of docetaxel/carboplatin vs. MIC/MVP chemotherapy in inoperable Advanced non-small cell lung cancer (NSCLC) — Do XPD polymorphisms predict for sensitivity or resistance to platinum based chemotherapy

✍ Booton, Richard; Campbell, Daniel; Ward, Tim; Ashcroft, L.; Power, Fiona; Taylor 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 348 KB

O-098 Survival equivalence of non-platin

O-098 Survival equivalence of non-platinum-based and platinum-basedchemotherapy for advanced non-small cell lung cancer (NSCLC): The results of a multicenter internet-based Phase III randomized study (D0112)

✍ Rigas, J.; Dragnev, K.; Kerry, M.; Cole, B.; Evans, A.; Page, R.; Yunus, F.; Rub 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P-21 A phase II trial of weekly paclitax

P-21 A phase II trial of weekly paclitaxel in advanced non-small cell lung cancer non-suitable for platinum-based chemotherapy. Spanish lung cancer group/GECP 00-02

✍ Massutí, Bartomeu; Camps, Carlos; Garrido, Pilar; Barceló, JoséRamón; Vin˜olas, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB